The Psychonauts’ World of Cognitive Enhancers

The Psychonauts’ World of Cognitive Enhancers

BackgroundThere is growing availability of novel psychoactive substances (NPS), including cognitive enhancers (CEs) which can be used in the treatment of certain mental health disorders. While treating cognitive deficit symptoms in neuropsychiatric or neurodegenerative disorders using CEs might have...

Full description

Bibliographic Details
Main Authors:	Flavia Napoletano, Fabrizio Schifano, John Martin Corkery, Amira Guirguis, Davide Arillotta, Caroline Zangani, Alessandro Vento
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-09-01
Series:	Frontiers in Psychiatry
Subjects:	cognitive enhancers nootropics novel psychoactive substances screening early warning systems
Online Access:	https://www.frontiersin.org/article/10.3389/fpsyt.2020.546796/full

Similar Items

Novel Opioids: Systematic Web Crawling Within the e-Psychonauts’ Scenario
by: Davide Arillotta, et al.
Published: (2020-03-01)

Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach
by: Valeria Catalani, et al.
Published: (2021-02-01)

Psychedelic Fauna for Psychonaut Hunters: A Mini-Review
by: Laura Orsolini, et al.
Published: (2018-05-01)

Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review
by: Fabrizio Schifano, et al.
Published: (2018-04-01)

Smart drugs are as a dangerous model of psychoactive substance use
by: Rychkova O.V.
Published: (2021-06-01)

Exploring the Baseline Knowledge and Experience of Healthcare Professionals in the United Kingdom on Novel Psychoactive Substances
by: Camille Ramos, et al.
Published: (2020-03-01)

The “Endless Trip” among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review
by: Laura Orsolini, et al.
Published: (2017-11-01)

CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor Agonist
by: Richard C. Kevin, et al.
Published: (2019-05-01)

Novel Psychoactive Substances (NPS): a Study on Persian Language Websites.
by: Imanollah Bigdeli, et al.
Published: (2013-05-01)

Assessing the 2004–2018 Fentanyl Misusing Issues Reported to an International Range of Adverse Reporting Systems
by: Fabrizio Schifano, et al.
Published: (2019-02-01)

The Bridge Between Classical and “Synthetic”/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective
by: Laura Orsolini, et al.
Published: (2019-11-01)

Exploration of the Use of New Psychoactive Substances by Individuals in Treatment for Substance Misuse in the UK
by: Rosalind Gittins, et al.
Published: (2018-03-01)

The prevalence of novel psychoactive substances (NPS) use in non-clinical populations: a systematic review protocol
by: Salma M. Khaled, et al.
Published: (2016-11-01)

Club Drugs: Psychotropic Effects and Psychopathological Characteristics of a Sample of Inpatients
by: Giovanni Martinotti, et al.
Published: (2020-08-01)

Application of High Resolution Mass Spectrometry for the Screening and Confirmation of Novel Psychoactive Substances
by: Seither, Joshua Zolton
Published: (2018)

Neurochemical and Behavioral Characterization after Acute and Repeated Exposure to Novel Synthetic Cannabinoid Agonist 5-MDMB-PICA
by: Aurora Musa, et al.
Published: (2020-12-01)

The analysis of admissions to the Emergency Department of the Psychiatric Hospital in Bielsko-Biała connected with psychotic disorders induced by psychoactive drug use
by: Magdalena Joanna Kaizer-Będkowska, et al.
Published: (2018-06-01)

Novel Psychoactive Substances (NPS): a Study on Persian Language Websites
by: Fabrizio Schi¬Fano, et al.
Published: (2013-05-01)

New Psychoactive Substances: Evolution in the Exchange of Information and Innovative Legal Responses in the European Union
by: Maria Rosaria Varì, et al.
Published: (2020-11-01)

The Pharmacological Profile of Second Generation Pyrovalerone Cathinones and Related Cathinone Derivative
by: Karolina E. Kolaczynska, et al.
Published: (2021-07-01)

Neurochemical and Behavioral Profiling in Male and Female Rats of the Psychedelic Agent 25I-NBOMe
by: Cristina Miliano, et al.
Published: (2019-12-01)

“New designer drugs” in aspects of forensic toxicology
by: Martyna Maciów-Głąb, et al.
Published: (2014-08-01)

Predictors of involuntary hospitalisation of patients suffering from schizophrenia
by: Ivana Stasevic Karlicic, et al.
Published: (2017-06-01)

Unusual/unconventional psychoactive substances of abuse
by: Anil Kakunje, et al.
Published: (2018-11-01)

Assessment of needs in improvement of clinical competences on therapy of dependencies from novel psychoactive substances in the Republic of Kazakhstan
by: Mariya Prilutskaya, et al.
Published: (2017-03-01)

Safety Profile and Neurocognitive Function Following Acute 4-Fluoroamphetamine (4-FA) Administration in Humans
by: Elizabeth B. de Sousa Fernandes Perna, et al.
Published: (2018-07-01)

In Vitro Neurochemical Assessment of Methylphenidate and Its “Legal High” Analogs 3,4-CTMP and Ethylphenidate in Rat Nucleus Accumbens and Bed Nucleus of the Stria Terminalis
by: Colin Davidson, et al.
Published: (2018-05-01)

An Expanding World of Novel Psychoactive Substances: Opioids
by: Jolanta B. Zawilska
Published: (2017-06-01)

Prescription Drug Misuse in “Clubbers” and Disco Goers in Ibiza
by: Massimo di Giannantonio, et al.
Published: (2020-12-01)

Worsening of the Toxic Effects of (±)<i>Cis</i>-4,4′-DMAR Following Its Co-Administration with (±)<i>Trans</i>-4,4′-DMAR: Neuro-Behavioural, Physiological, Immunohistochemical and Metabolic Studies in Mice
by: Micaela Tirri, et al.
Published: (2021-08-01)

New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature
by: Stefania Chiappini, et al.
Published: (2021-06-01)

New Synthetic Cannabinoids Metabolism and Strategies to Best Identify Optimal Marker Metabolites
by: Xingxing Diao, et al.
Published: (2019-03-01)

Evidence for public health on novel psychoactive substance use: a mixed-methods study
by: Kathryn Higgins, et al.
Published: (2019-08-01)

Suicidal Behavior and Club Drugs in Young Adults
by: Giovanni Martinotti, et al.
Published: (2021-04-01)

Characteristics of psychiatric inpatients diagnosed with mental and behavioral disorders caused by psychoactive substances (F11-19 block), with a focus on NPS and psychiatric co-morbidities
by: Piotr Engelgardt, et al.
Published: (2020-03-01)

Determinants of knowledge and use of psychoactive substance among commercial motorcyclist in Sokoto metropolis, Northwest Nigeria
by: M.O.Raji
Published: (2017-01-01)

Uwagi w związku z przygotowanym przez władze miasta Leszna projektem przepisów karnych mających na celu zwalczanie obrotu tak zwanymi dopalaczami
by: Łukasz Pohl
Published: (2018-01-01)

Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson’s Disease
by: Carla Ferreira, et al.
Published: (2020-06-01)

Neuropharmacology of new psychoactive substances (NPS): focus on the rewarding and reinforcing properties of cannabimimetics and amphetamine-like stimulants
by: Cristina eMiliano, et al.
Published: (2016-04-01)

“Hot” and “Cold” Cognition in Users of Club Drugs/Novel Psychoactive Substances
by: George Savulich, et al.
Published: (2021-03-01)

Cannot write session to /tmp/vufind_sessions/sess_sjtmggi118ke2l1c4bj0eihghk